Patent Assignment
Reel/Frame 012748/0271
Assignment of Assignor's Interest
Recorded: 2002-03-25
Pages: 3
Assignor
WANG, GUANGYI
Executed: 2001-11-21
Assignee
ICN PHARMACEUTICALS, INC.
3300 HYLAND AVENUE, COSTA MESA, CALIFORNIA, 92626
Covered Property
(1)
Novel Nucleosides Having Bicyclic Sugar Moiety
Patent:
6,403,566 →
Application:
09/451,708 →
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Contribution Agreement
Mar 27, 2005
From: ICN PHARMACEUTICALS, INC.
To: RIBAPHARM INC.
Reel/Frame 015819/0595 →
Change of Name
Aug 24, 2005
From: RIBAPHARM INC.
To: VALEANT RESEARCH & DEVELOPMENT
Reel/Frame 016446/0026 →
Assignment of Assignor's Interest
Apr 14, 2010
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: MDRNA, INC.
Reel/Frame 024233/0034 →
Security Agreement (Patents)
Apr 28, 2010
From: MDRNA, INC. FKA NASTECH PHARMACEUTICAL COMPANY INC.
To: CEQUENT PHARMACEUTICALS, INC.
Reel/Frame 024300/0825 →
Release of Security Interest
Jul 30, 2010
From: CEQUENT PHARMACEUTICALS, INC.
To: MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
Reel/Frame 024767/0466 →
Security Agreement
Feb 15, 2012
From: MARINA BIOTECH, INC; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
Reel/Frame 027712/0200 →
Security Agreement
May 13, 2013
From: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: MONSANTO COMPANY
Reel/Frame 030401/0461 →
Release of Security Interest
Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →